Trials / Completed
CompletedNCT05109884
Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer
Comparison of PET Imaging Patterns With Prostate-specific Membrane Antigen and Androgen Specific Receptor Expression Patterns in Prostate Cancer and Bladder Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients suffering either from newly diagnosed very high risk locally advanced and/or oligometastatic prostate cancer (cohort A), metastatic castration-resistant prostate cancer (mCRPC, cohort B), newly diagnosed postate cancer with planned radical prostatectomy (cohort C) or primary bladder cancer with planned radical cystectomy (cohort D) as identified by a multidisciplinary team of specialists, will be included. PET imaging patterns using PSMA- and FDHT PET scans will be correlated with prostate-specific membrane antigen and androgen specific receptor expression patterns in prostate cancer and bladder cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PSMA PET Scan | \[68Ga\]Ga-PSMAHBED-CC (Ga-PSMA) PET Scan |
| DIAGNOSTIC_TEST | FDHT PET Scan | \[18F\]-fluoro-5α-dihydrotestosterone (18F-FDHT) PET Scan |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2021-04-19
- Completion
- 2021-04-19
- First posted
- 2021-11-05
- Last updated
- 2023-03-17
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT05109884. Inclusion in this directory is not an endorsement.